A New Method for Cardiac Diseases Diagnosis

Abstract

The objective of this work is to perform automatic diagnosis using a non invasive method which consists on the bioimpedance signal processing. Bioimpedance signal (BIS) represents the aorta impedance variation during the heart cycle activity. BIS is detected by mean of two electrodes located at the level of the ascendant aorta. Automatic diagnosis method consists on preparing, first, a data base with a set of cepstral parameters of different BIS according to normal case and different cardiac diseases. This data base is composed from n classes Yk corresponding to n diseases. The classification of anonymous individuals is based on the determination of Fisher distance between anonymous disease and class Yk using Fischer formula. Our method permits to calculate seven relevant cepstral parameters. The application of Fisher method has allowed us to perform the diagnosis of five anonymous cases. The major interest of this method is its especially useful for the exploration of cardiovascular system anomalies for emergency cases, children, elderly and pregnant women who can’t support surgical operations especially at the level of the heart.

Share and Cite:

Salah, R. , Alhadidi, T. , Mansouri, S. and Naouar, M. (2015) A New Method for Cardiac Diseases Diagnosis. Advances in Bioscience and Biotechnology, 6, 311-319. doi: 10.4236/abb.2015.64030.

1. Introduction

Several studies have been performed on medical signal processing with the aim of enriching the table in diagnosis of heart disease [1] -[4] . These signals include the ECG [1] signal, bioimpedance cardiovascular signal, doppler signal [4] -[6] , phonocardiogram signal… However, the majority of the work in this area remains targeted on a temporal signal processing allowing the computation of Cardiac output, cardiac frequency, systolic ejection duration, systolic ejection fraction [6] -[11] … The objective of this study is to design an automatic diagnosis of the cardio-vascular anomalies via a cepstral signal analysis. Our analysis shows the importance of the cepstral parameters for the classification of various cardiovascular diseases. In this work we proceed first to the description of the bioimpedance method, then we describe the signals cepstral approach [8] . The method of discriminant analysis [8] will enable us to confirm the relevance of the cepstral parameters in the cardiovascular diseases diagnosis. Cepstral parameters will be used then for the automatic diagnosis.

2. Material and Method

2.1. Bioimpedance Method

The method used in this study consists of applying a low level rectangular current and high frequency (1 mA, 30 kHz), through a pair of electrodes placed respectively in the front and above the leading edge of the heart [12] -[15] . Another pair of electrodes, placed on the chest of the patient at the level of aorta 2 or 3 cm apart, permit perception of bioimpedance signal [BIS] representing impedance variation ∆Z of the explored thoracic region. Figure 1, shows the electrode configuration for the measurement of the bioimpedance signal.

The aim of this bioimpedance signal analysis is the diagnosis of cardiac diseases by means of cepstral processing of this signal using Fisher theory [16] -[18] .

2.2. Cepstral Analysis

Cepstral method consists on considering that bioimpedance signal y(t) is the response of left ventricle aorta system to a cardiac excitation signal x(t) and the aorta pulsatile response h(t) (Figure 2):

Then:

(1)

(Temporal convolution product)

Cepstral analysis consists on the determination of excitation signal x(t) and pulsatile response h(t), in order to describe, separately, anomalies, respectively, in heart and aorta. Computation is carried out at the minimum phase (Φ = 0).

Let:

(2)

(3)

Figure 1. Bioimpedance method.

Figure 2. Cepstral model.

where:

(4)

(5)

(6)

Let:

(7)

(8)

y1(t) is the Cepstre C1

where:

(9)

(10)

Let:

(11)

(12)

(13)

(14)

Let:

(15)

is the Cepstre C2

(16)

is the Cepstre C3.

and are considered as the original signal provided, respectively, by heart and aorta.

Figure 3, shows the different steps of the cepstral algorithm.

3. Result and Discussion

3.1. Temporal, Spectral and Cepstral Parameters

Early, a statistical study, using the discriminant method analysis, has been performed [17] [18] . This study consists to use 15 parameters: five temporal variables from bioimpedance signal and its derivative (A, C, O, X, S), 3 spectral parameters (r1, r2, r3) and seven cepstrals variables (U, M, N, F, I, G, LF) (Figure 4 and Figure 5) and (Table 1).

Our idea in this study is to use the seven cepstral parameters for the automatic diagnosis of the heart disease

Figure 3. Cepstral analysis.

Figure 4. Temporal parameters.

using Fisher’s test. Cesptres C2 and C3 permit to provide these seven relevant parameters: U, M, N, F, I, G, LF (Table 2).

3.2. Discriminant Analysis Method

The principle of discriminant analysis is based on FISCHER theory and the criteria of “Step by Step”. The relevant plethysmographic parameters represent the set of parameters which allows having the maximum of matrix product T−1 E. Where T is whole covariance matrix, E is the interclass covariance matrix. The classification of anonymous individuals is based on the use of the FISHER formula [16] :

(17)

is the Fisher distance between an anonymous individual and class Yk, a is the anonymous individual defined by cepstral parameters, yk is the average of Yk classes, Tcov is whole covariance matrix.

Figure 5. C2 and C3 cepstral parameters.

Table 1. Temporal, spectral and cepstral parameters.

Table 2. Cepstral parameters.

Computed algorithms are expressed by a MAHAL 3 program [5] . The determination of the best discriminant parameters is carried out at each step from a basic sample (normal and cardiovascular diseases) with a dimension N calculated as follows with an error risk of 5% [8] [17] :

(18)

P is the total of average cepstral parameters corresponding to 25 classes (Table 3)

Bioimpedance parameters, proposed for the discrimination between the classes, are in this study 7 cepstral parameters.

After testing the seven parameters during the first step, the program indicates the parameter number 7 which represents the normalized width LF of the aortic cepstral. Therefore, the parameter number 7 is the best discriminant plethismographic parameter. The best classified percentage of individual is then 64.29% (Table 3).

At steps number 2, 3 and 4, the program choose, respectively, parameters number 7, 5, 6 and 4 corresponding respectively to the parameters: LF, I, G and F. The classified percentage is then 86.01%. At step 5, the percentage of classification reaches 93.66% the parameters are 7, 5, 6, 4, and 3 corresponding to the parameters: LF, I, G, F and N. Finally at step number 6 and 7 the program choose parameters 2 and 1 corresponding to M and U respectively with the percentage 94.1% and 95.4%.

The total 7 independent parameters (Table 4), gives 99.4% degree of best classification. Therefore Bioimpedance cepstral parameters with best discrimination are: 7(Lf), 5(I), 6(G), 4(F), 3(N), 6(M), and 7(U).

3.3. Automatic Diagnosis

Automatic diagnosis method consists on preparing, first, a data base with a set of the seven cepstral parameters

Table 3. Basic sample of average cepstral parameters.

(AO.I: aortic insufficiency; AO.S: aortic stenosis; AO.D: aortic diseases; M.I: Mitral Insufficiency; M.S: Mitral stenosis; M.D: Mitral diseases; PS: pulmonary stenosis; IVC: Inter-ventricle communication; IAC: inter-atrium communication; CMP: Cardio-myopathie).

of different bioimpedance signal according to different cardiac diseases and the formula (18). This data base is composed from n classes Yk corresponding to 25 cases (normal and cardiac disease).

The classification of anonymous individuals is based on the use of FISHER formula (8). Minimum dm distance, between a and the Yk, classes provides the kind of cardiac disease. Investigation has concerned a data base of 25 kinds of signal: one normal and 24 pathological cases (Table 3). The number of cross indicates the severity of the disease.

Three cases of anonymous signals are used (a1: AO.S+), (a2: M.S++) and (a3: M.S+++). The diagnosis of these three anonymous cases is confirmed by Echo-Doppler method. Table 5 shows affectation of these cases.

Table 4. Step by step analysis.

Table 5. Anonymous individual affection.

3.4. Discussion

From Table 4, it can be noted that the parameter 7 (LF) has the best discriminating power with a percentage of well class 64.29%, which confirms the results found by Ben Salah et al. [8] [17] .

At step 7 the percentage of well class reaches 95.40%. This result is slightly better than the one we found in previous work using 15 bioimpedance parameters: 94.64% of percentage of correctly classified.

The results found in this work indicate that the seven cepstral parameters defined above are sufficient to perform the automatic diagnosis of the cardiovascular system abnormalities.

The effectiveness of the cepstral parameters classification is confirmed by the exact allocation of 3 anonymous individuals. Indeed our results demonstrate that patients a1, a2, a3 have been allocated respectively to the previous classes: AO.S+ (d = 0.1), M.S.++ (d = 0.1), and D.M.+++ (d = 0.02).

4. Conclusion

Automatic quantification of cardiac diseases has been carried out using discriminant analysis method based on the processing of bioimpedance signal. The discrimination uses analysis of seven cepstral parameters. Classifi- cation has been performed using e fundamental data base composed of 25 classes (one normal and 24 cases of diseases). “Step by step” method gives an excellent degree of discrimination 954%. The intelligent method performed in this study permits to confirm the classification of three anonymous patients. Quantification results obtained by the bioimpedance signals analysis are confirmed by those obtained with Echo-Doppler method. Researches are actually orientated for the investigation of peripheral cardiovascular system with the use of hemodynamic bioimpedance and ECG parameters.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Yan, J.Y., Lu, Y., Liu, J. and Wu, X.Y. (2010) Intelligent Diagnosis of Cardiovascular Diseases Utilizing ECG Signals. International Journal of Information Acquisition, 07, 81.
http://dx.doi.org/10.1142/S0219878910002087
[2] Kumaravel, N., Sridhar, K.S. and Nithiyanandam, N. (1996) Automatic Diagnosis of Heart Diseases Using Neural Network. Biomedical Engineering Conference, Dayton, 29-31 March 1996, 319-322.
http://dx.doi.org/10.1109/SBEC.1996.493214
[3] Hong, B., Kai, J., Ren, Y., Han, J., Zou, Z., Ahn, C.H. and Kang, K.A. (2008) Highly Sensitive Rapid, Reliable, and Automatic Cardiovascular Disease Diagnosis with Nanoparticle Fluorescence Enhancer and Mems. Advances in Experimental Medicine and Biology, 614, 265-273.
http://dx.doi.org/10.1007/978-0-387-74911-2_30
[4] Scherhag, A.W., et al. (2013) Continuous Measurement of Hemodynamic Alterations during Pharmacologic Cardiovascular Stress Using Automated Impedance Cardiography. The Journal of Clinical Pharmacology, 37, 21S-28S.
[5] Fortin, J., et al. (2006) Non-Invasive Beat-To-Beat Cardiac Output Monitoring by an Improved Method of Transthoracic Bioimpedance Measurement. Computers in Biology and Medicine, 36, 1185-1203.
http://dx.doi.org/10.1016/j.compbiomed.2005.06.001
[6] Kubicek, W.G., Karnegis, J.N., Patterson, R.P., Witsoe, D.A. and Mattson, R.H. (1966) Development and Evaluation of an Impedance Cardiac Output System. Aerospace Medicine, 37, 1208-1212.
[7] Bizouarn, P., Blanloeil, Y. and De La Coussaye, J.E. (1996) Conférences d’actualisation “Méthodes de mesure du débit cardiaque en réanimation”. Elsevier, Paris, et Société Française d’Anesthésie et de Réanimation (SFAR), 377-398.
[8] Ben Salah, R. (1988) Pléthysmographie électrique thoracique localisée. Application à la détermination des paramètres cardiovasculaires et au diagnostic des cardiopathies. Ph.D. Faculté des sciences de Tunis.
[9] Chemam, M.N. (1983) Analyse automatique des signaux pléthysmographiques. Application à la mesure du débit sanguin et à la reconnaissance des cardiopathies. Ph.D. Dissetation, ENIT, Tunis.
[10] Collete, M., Leftheriotis, G. and Humeau, A. (2009) Modeling and Interpretation of the Bioelectrical Impedance Signal for the Determination of the Local Arterial Stiffness. Medical Physics, 36, 4340-4348.
http://dx.doi.org/10.1118/1.3213084
[11] Ivorra, A. (2002) Bioimpédance Monitoring for Physicians: An Overview. Centre Nacional de Microelectrònica, Barcelona, Spain.
[12] Kubicek, W.G., Patterson, R.P. and Witsoe, D.A. (1970) Impedance Cardiography as a Non Invasive Method of Monitoring Cardiac Function and Other Parameters of the Cardiovascular System. Annals of the N. Y. Academy of Sciences, 170, 724-732.
http://dx.doi.org/10.1111/j.1749-6632.1970.tb17735.x
[13] Mansouri, S., Mahjoubi, H. and Ben Salah, R. (2010) Determination of Instantaneous Arterial Blood Pressure from Bio-Impedance Signal. Journal of Biophysics and Structural Biology, 2, 009-015.
[14] Mansouri, S., Mahjoubi, H. and Ben Salah, R. (2009) FPGA-Based Derivative Module for Bioimpedance Signal. International Journal of Computer Science and Network Security, 9, 16-20.
[15] Mansouri, S. (2011) Conception d’un système de détermination non invasive des paramètres biorhéologiques cardiovasculaire par la méthode de bioimpédance périphérique. Ph.D. Faculté des sciences de Tunis.
[16] Romeder, J.M. (1973) Méthode et programme d’analyse discriminante, Dunod.
[17] Ben Salah, R., et al. (1988) Temporal, Spectral and Cepstral Analysis of Plethysmographic Signal. Application to Automatic Diagnosis of Cardiac Diseases. Signal Processing IV. Thories and Applications. Elsevier Science Publishers B. V., North Holland.
[18] Ben Salah, R. and Mansouri, S. (2008) Automatical Diagnosis of Cardiac Diseases by Cepstral Processing of the Bioimpédance Signal. 3rd IEEE International Conference on information and Communication Technologies: From Theory to Applications. Damascuc, 7-11 April 2008, 7-11.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.